JBM (Healthcare) Limited provided unaudited consolidated earnings guidance for the year ended March 31, 2024. For the year, the company expects to record an increase in the consolidated profit attributable to Shareholders for the year ended 31 March 2024 by not less than 120% as compared to that for the year ended 31 March 2023.